Lazar Vujanović

1.9k total citations · 1 hit paper
39 papers, 1.1k citations indexed

About

Lazar Vujanović is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lazar Vujanović has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 21 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Lazar Vujanović's work include Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Immune Cell Function and Interaction (11 papers). Lazar Vujanović is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Immune Cell Function and Interaction (11 papers). Lazar Vujanović collaborates with scholars based in United States, Germany and Brazil. Lazar Vujanović's co-authors include Lisa H. Butterfield, Robert L. Ferris, Tullia C. Bruno, Dan P. Zandberg, Ayana T. Ruffin, Nikola L. Vujanović, John M. Kirkwood, Walter J. Storkus, Simon C. Watkins and Yan Lin and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lazar Vujanović

36 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

2022 175 citations Ayana T. Ruffin, Lazar Vujanović et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lazar Vujanović United States	19	648	588	318	112	107	39	1.1k
Iva Truxová Czechia	16	729 1.1×	648 1.1×	299 0.9×	94 0.8×	61 0.6×	24	1.2k
Melanie Straub Germany	10	439 0.7×	518 0.9×	426 1.3×	66 0.6×	53 0.5×	19	913
Malgorzata Harasymczuk United States	13	740 1.1×	462 0.8×	325 1.0×	176 1.6×	47 0.4×	16	1.1k
Yvette Robbins United States	14	675 1.0×	614 1.0×	187 0.6×	78 0.7×	30 0.3×	29	991
Daniel R. Vlock United States	17	299 0.5×	447 0.8×	332 1.0×	163 1.5×	121 1.1×	32	916
Michelle C.R. Yong Australia	16	834 1.3×	982 1.7×	209 0.7×	87 0.8×	28 0.3×	18	1.5k
Ailem Rabasa Cuba	9	276 0.4×	373 0.6×	202 0.6×	40 0.4×	50 0.5×	14	681
Nicholas D. Stafford United Kingdom	14	148 0.2×	327 0.6×	174 0.5×	137 1.2×	135 1.3×	31	617
Akira Yuno United States	16	383 0.6×	411 0.7×	459 1.4×	66 0.6×	14 0.1×	29	844
Michelle R. Padget United States	15	579 0.9×	724 1.2×	267 0.8×	75 0.7×	10 0.1×	22	1.0k

Countries citing papers authored by Lazar Vujanović

Since Specialization

Citations

This map shows the geographic impact of Lazar Vujanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lazar Vujanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lazar Vujanović more than expected).

Fields of papers citing papers by Lazar Vujanović

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lazar Vujanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lazar Vujanović. The network helps show where Lazar Vujanović may publish in the future.

Co-authorship network of co-authors of Lazar Vujanović

This figure shows the co-authorship network connecting the top 25 collaborators of Lazar Vujanović. A scholar is included among the top collaborators of Lazar Vujanović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lazar Vujanović. Lazar Vujanović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zandberg, Dan P., Lazar Vujanović, David A. Clump, et al.. (2025). Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 43(23). 2572–2582.

Adamik, Juraj, Hongzhi Wang, Mary Jo Buffo, et al.. (2025). Serum Arginase−1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness. OncoImmunology. 14(1). 2595764–2595764.

Earland, Noah, Lazar Vujanović, D. Elias, et al.. (2024). Abstract B031: Immune cell composition in surgical drain fluid as a novel prognostic marker in head and neck squamous cell carcinoma. Clinical Cancer Research. 30(21_Supplement). B031–B031. 1 indexed citations

Contrera, Kevin J., Matthew E. Spector, Liron Pantanowitz, et al.. (2024). CD8 ⁺ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A Review. JCO Precision Oncology. 8(8). e2400183–e2400183.

Sorroche, Bruna Pereira, et al.. (2023). PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors’ Response and Survival in Advanced Melanoma Patients in Brazil. Diagnostics. 13(6). 1041–1041. 13 indexed citations

Chen, Xueer, Lujia Chen, Cornelius Kürten, et al.. (2022). An individualized causal framework for learning intercellular communication networks that define microenvironments of individual tumors. PLoS Computational Biology. 18(12). e1010761–e1010761. 3 indexed citations

Ruffin, Ayana T., et al.. (2022). Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nature reviews. Cancer. 23(3). 173–188. 175 indexed citations breakdown →

Santos, Patrícia, Aditi Kulkarni, Jie Chen, et al.. (2022). 683 CD8 T cell repertoire analysis of patients with resectable head and neck cancer enrolled in a phase II neoadjuvant study of α-PD1 administered alone or in combination with α-CTLA4 or α-LAG3. Regular and Young Investigator Award Abstracts. A713–A713. 1 indexed citations

Ferris, Robert L., William C. Spanos, Rom S. Leidner, et al.. (2021). Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial. Journal for ImmunoTherapy of Cancer. 9(6). e002568–e002568. 126 indexed citations

10.

Kulkarni, Aditi, Uma Chandran, Alexander Chang, et al.. (2021). Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment. Cell Reports. 36(11). 109699–109699. 62 indexed citations

11.

Gorry, Michael C., Toshie Yoneyama, Lazar Vujanović, et al.. (2019). Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells. Journal of Cancer. 11(3). 702–715. 9 indexed citations

12.

Yoneyama, Toshie, Michael C. Gorry, Andrea Sobo-Vujanovic, et al.. (2018). ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker. Journal of Cancer. 9(14). 2559–2570. 32 indexed citations

13.

Vujanović, Lazar, Elizabeth C. Stahl, Angela D. Pardee, et al.. (2017). Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer–Cell Activation and Subsequent Cell Death. Cancer Immunology Research. 5(6). 493–502. 27 indexed citations

14.

Sobo-Vujanovic, Andrea, Lazar Vujanović, Albert B. DeLeo, et al.. (2016). Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice. Cancer Immunology Research. 4(5). 441–451. 29 indexed citations

15.

Pardee, Angela D., Hiroshi Yano, Aliyah M. Weinstein, et al.. (2015). Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 3(1). 32–32. 23 indexed citations

16.

Vujanović, Lazar, et al.. (2013). Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma. Journal for ImmunoTherapy of Cancer. 1(1). 19–19. 5 indexed citations

17.

Landsberg, Jennifer, Michelle N. Messmer, Jian Shi, et al.. (2012). Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity. OncoImmunology. 1(3). 287–357. 20 indexed citations

18.

Ge, Lisheng, Dejan Baskić, Per Basse, et al.. (2009). Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer. Cancer Epidemiology Biomarkers & Prevention. 18(11). 2913–2922. 18 indexed citations

19.

Butterfield, Lisa H., Begonya Comin-Anduix, Lazar Vujanović, et al.. (2008). Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma. Journal of Immunotherapy. 31(3). 294–309. 84 indexed citations

20.

Vujanović, Lazar, Elena Ranieri, Andrea Gambotto, et al.. (2006). IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. Cancer Gene Therapy. 13(8). 798–805. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact